Y
Yan Zhou
Researcher at Capital Medical University
Publications - 17
Citations - 393
Yan Zhou is an academic researcher from Capital Medical University. The author has contributed to research in topics: Apoptosis & Downregulation and upregulation. The author has an hindex of 11, co-authored 17 publications receiving 307 citations.
Papers
More filters
Journal ArticleDOI
Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia
Fu-Chun Zhou,Yu-Tao Xiang,Yu-Tao Xiang,Chuanyue Wang,Faith Dickerson,Raymond W.C. Au,Jing Jing Zhou,Yan Zhou,David Shum,Helen F.K. Chiu,David W. K. Man,Edwin Ho Ming Lee,Xin Yu,Raymond C.K. Chan,Gabor S. Ungvari +14 more
TL;DR: Both subtypes of PM are impaired in first-episode schizophrenia suggesting that PM deficits are an integral part of the cognitive dysfunction in the disease process.
Journal ArticleDOI
Sulforaphane Inhibits Invasion via Activating ERK1/2 Signaling in Human Glioblastoma U87MG and U373MG Cells
TL;DR: Sulforaphane might be a potential therapeutic agent by activating ERK1/2 signaling against human glioblastoma by inhibiting migration and invasion processes.
Journal ArticleDOI
Sulforaphane Induced Apoptosis via Promotion of Mitochondrial Fusion and ERK1/2-Mediated 26S Proteasome Degradation of Novel Pro-survival Bim and Upregulation of Bax in Human Non-Small Cell Lung Cancer Cells.
TL;DR: It is demonstrated for the first time that alteration of mitochondrial dynamics contributed to SFN-induced apoptosis in human non-small cell lung cancer (NSCLC) cells.
Journal ArticleDOI
Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells
TL;DR: Sulforaphane is a prospective therapeutic agent that may be used to prevent invasion in prostate cancer by activating ERK1/2 to upregulate E-cadherin and downregulate CD44v6, thereby reducing MMP-2 expression and activity.
Journal ArticleDOI
Human chorionic gonadotropin β induces migration and invasion via activating ERK1/2 and MMP-2 in human prostate cancer DU145 cells.
TL;DR: Results indicated that hCGβ induced cell motility via promoting ERK1/2 phosphorylation and MMP-2 upregulation in human prostate cancer DU145 cells.